Results 41 to 50 of about 115,229 (304)
Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study [PDF]
, 2012 Objective: To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design: Prospective, propensity score matched cohort study.
Bateman, Brian Thomas +9 more
core +1 more source
Application of peripheral nerve and muscle ultrasound in neuromuscular diseases
Chinese Journal of Contemporary Neurology and Neurosurgery, 2023 Peripheral nerve and muscle ultrasound (hereinafter referred to as neuromuscular ultrasound) has been increasingly widely used in neuromuscular diseases, which can not only reflect the morphological characteristics of neuromuscular, but also serve as an ...
LIU Ming‑sheng
doaj +1 more source
Sugammadex for reversal of neuromuscular blockade: A retrospective analysis of clinical outcomes and cost-effectiveness in a single center [PDF]
, 2016 OBJECTIVE: The aim of the study is to evaluate the clinical and economic impact of introducing a rocuronium-neostigmine-sugammadex strategy into a cisatracurium-neostigmine regimen for neuromuscular block (NMB) management.
BARATTO, FABIO +3 more
core +1 more source
Neuromuscular monitoring during anesthesia [PDF]
, 2007 Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open í sviðinuObjective: Muscle relaxants are very important in anesthetic practice but must be used with great care.
Erla G. Sveinsdóttir +1 more
core
Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Variants in the FHL1 gene cause FHL1‐related myopathies (FHL1‐RMs), a group of neuromuscular disorders with diverse clinical presentations. This study aimed to comprehensively characterize the spatial and temporal patterns of skeletal muscle fat replacement throughout the whole body in FHL1‐RMs, to examine disease progression over ...
Rui Shimazaki +8 more
wiley +1 more source
Incorrect monitoring settings can mimic residual neuromuscular blockade: A case report
JCA AdvancesSugammadex reliably reverses rocuronium-induced neuromuscular blockade by forming a 1:1 complex with rocuronium; however, incomplete or recurrent blockade can still occur.
Yuto Rai, M.D. +4 more
doaj +1 more source
Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew +11 more
wiley +1 more source
BMC Anesthesiology, 2018 Background Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency medicine ...
Hans D de Boer +2 more
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Home oxygen for children: who, how and when? [PDF]
, 2005 A review of the specific requirements of home oxygen therapy in children which attempts to offer guidance to clinicians and service ...
Balfour-Lynn, I.M. +2 more
core +2 more sources